David Moller
About David Moller
David Moller Chief Scientific Officer
David Moller serves as the Chief Scientific Officer, bringing over 20 years of extensive experience in leading R&D efforts in the pharmaceutical and biotech sectors. His role involves overseeing both research and clinical development, focusing on translating genetic insights into therapeutic programs.
David Moller Experience in Pharmaceutical Industry
David Moller's career spans over two decades, during which he has held significant research and development leadership positions at renowned pharmaceutical companies such as Eli Lilly and Merck. His expertise includes guiding scientific teams and projects that lead to the development of innovative therapeutics.
David Moller Physician-Scientist Expertise
David Moller is a physician-scientist with specialized training that combines medical and scientific knowledge. This dual expertise allows him to bridge the gap between genetic research and the practical development of therapeutic programs, enhancing his ability to lead R&D efforts in both clinical and research settings.
David Moller Contributions to Medicine Development
David Moller has played a key role in the development of several successful medicines, including Januvia (sitagliptin), Trulicity (dulaglutide), and Mounjaro (tirzepatide) injection. His contributions have significantly advanced the treatment options available for patients, particularly in the realms of metabolic and endocrine disorders.